跳至主要内容
临床试验/PACTR202303697293140
PACTR202303697293140尚未招募3 期

Oral antenatal L-citrulline supplementation to reduce adverse pregnancy outcomes: a two-arm, randomized, placebo-controlled multi-site trial in Kenya (L-ArGinine to pRevent advErse prEgnancy outcomes (AGREE).

The Liverpool School of Tropical Medicine0 个研究点目标入组 2,960 人开始时间: 2023年3月22日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
2,960

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Pregnant women aged 16 to 40 years,
  • Gestation should be less than 24 weeks cornfirmed by ultrasound
  • The pregnancy should be viable singleton pregnancy
  • The woman should be a residents of the study area, willing to adhere to scheduled and unscheduledstudy visit procedures, and willing to deliver in a study clinic or hospital.

排除标准

  • Multiple pregnancies
  • Pre-existing hypertension,
  • women with renal disease and/or diabetes, or severe anaemia (Hb < 5 g/dL)
  • HIV-positive women
  • Malformations or nonviable pregnancy observed on enrolment ultrasound
  • known allergy or contraindication to any of the study supplements
  • unable to give consent
  • Concurrent participation in any other clinical trial

研究者

发起方
The Liverpool School of Tropical Medicine

相似试验